ARN-2508

N/A

Report date: 2025/01/26 15:06:34
NME

Base Information

Drug NameARN-2508
Drug Alias NameARN-2508
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsAnandamide amidohydrolase inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-1Anandamide amidohydrolaseCyclooxygenase-2
Therapy Area/IndicationsPainInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of California Irvine
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of California Irvine
Inactive CompaniesN/A
Active IndicationsPainInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A